Xiaoxi Liu

Xiaoxi Liu has a diverse work experience that spans several prestigious institutions. They began their career as a Postdoctoral Research Associate at the University of Vermont in 2014, where they developed a novel synthesis methodology and studied intermolecular recognition. Following this, Liu worked as a Research Fellow at Harvard Medical School from 2016 to 2019. During this time, they also held a concurrent position as a Scientist I at the Dana-Farber Cancer Institute, where they spearheaded a medicinal chemistry campaign and evaluated lead compounds. Liu's most recent role is at Neomorph, Inc., where they started as a Scientist II in 2021 and currently hold the position of Senior Scientist. No end dates are provided for their roles at Neomorph, Inc., indicating that they are still employed there.

Xiaoxi Liu completed a Doctor of Philosophy (Ph.D.) in Organic Chemistry from the University of Vermont, studying from 2008 to 2014. Prior to this, there is no available information on Xiaoxi Liu's education at Tianjin Medical University, as the start and end years, as well as the degree name and field of study, are not provided.